Merlin CP-GEP Becomes the First and Only Gene Expression Profile Test Recommended by NCCN®
San Diego, CA & Rotterdam, Netherlands- February 19, 2026 — SkylineDx today announced that the National Comprehensive Cancer Network® (NCCN®) has updated its…
02/19/2026
Merlin CP-GEP Becomes the First and Only Gene Expression Profile Test Recommended by NCCN®
San Diego, CA & Rotterdam, Netherlands- February 19, 2026 — SkylineDx today announced that the National Comprehensive Cancer Network® (NCCN®) has updated its…
|
|
02/05/2026
Best-in-Class Real-World Data Support Early Amtagvi® Treatment in Advanced Melanoma
52% Amtagvi Response Rate with Two or Fewer Prior Lines of Therapy 73% Overall Disease Control Rate SAN CARLOS, Calif., Feb.…
|
|
01/23/2026
Moderna, Merck’s Skin Cancer Vaccine Shows Sustained Benefit in Five-Year Follow-Up
By Kamal Choudhury and Mariam E SunnyJanuary 20, 2026 3:52 PM EST Jan 20 (Reuters) – Moderna (MRNA.O), opens new tab and Merck…
|
01/21/2026
Reflecting on Melanoma Treatment in 2025 and Looking to the Future in 2026
The start of a new year is a time for reflection and looking to the future. This is an ideal…
|
01/13/2026
The Integrative Care Approach
Guest: Lisa Simms Booth, Executive Director, Smith Center for Healing and the Arts In this episode of the Beyond the…
|
01/13/2026
Improved Response to Immunotherapy with COVID-19 mRNA Vaccines
Introduction Data from a new study presented at the European Society for Medical Oncology (ESMO) meeting and published in Nature…
|
12/09/2025
One Day at a Time: Caregiving Through Ocular Melanoma
In this episode, we sit down with Vanessa Tompkins, wife and caregiver to Mike, who has been battling Stage IV…
|
11/24/2025
A Life Rewritten: Finding Strength in the Face of Melanoma
By Mara Klecker Just Normal People Asked to describe his life before the first melanoma diagnosis—before losing an eye, undergoing…
|
11/20/2025
Living Through TIL Therapy: A Personal Story
By Mara Klecker Michael Moran shared his personal journey with melanoma to inspire, educate, and support others affected by this…
|
11/07/2025
You’re Not Out of Options: What to Do When First-Line Melanoma Treatment Fails
Melanoma treatment has advanced dramatically over the past decade, with immunotherapy and targeted therapies offering hope for many patients. However,…
|
Recent Posts
Feb. 19, 2026
Merlin CP-GEP Becomes the First and Only Gene Expression Profile Test Recommended by NCCN®
Feb. 05, 2026
Best-in-Class Real-World Data Support Early Amtagvi® Treatment in Advanced Melanoma
Jan. 23, 2026
Moderna, Merck’s Skin Cancer Vaccine Shows Sustained Benefit in Five-Year Follow-Up
Jan. 21, 2026
Reflecting on Melanoma Treatment in 2025 and Looking to the Future in 2026
Jan. 13, 2026